Wisconsin-Based iMark Molding Plans $18 Million Expansion
Custom injection molder iMark Molding Inc. will spend $18 million to expand and upgrade its Woodville, Wis., operation.
The centerpiece of the project will be a 22,500-square-foot pharmaceutical grade clean room, which will be expandable by another 18,000 square feet. The project also entails tripling the size of its 38,640-square-foot current facility by the end of 2018, renovating the building and adding more equipment.
"The result of this expansion will be a world-class molding facility that will solidify iMark's position as the leader in supporting Wisconsin's biohealth industry and will help meet the needs of life science companies nationwide," iMark President Mark Sturtevant, who founded the company in 2000, said in a news release.
The company specializes in molding components for medical and diagnostic applications. The firm is striving to become compliant with ISO 18385, a new standard that minimizes the risk of human DNA contamination in products used to collect, store and analyze biological material for forensic and diagnostic purposes.
The 70-employee Woodville operation is a 45-mile drive to the Minneapolis-St. Paul, Minn., area, a hotbed of medical products development and production.
The facility expansion includes adding 32,000 square feet of manufacturing, 28,000 square feet of warehouse and shipping and 20,000 square feet of office area.
Sturtevant founded iMark to create a molding company that goes beyond the norm. The company puts a lot of resources into quality control as it implements 5S workplace organization methods. It monitors mold cavity pressure to detect defects and ensure accurate parts are molded. It runs an extensive metrology laboratory that includes a Zeiss coordinate measuring machine.
"iMark is the latest example of the many companies choosing to establish or expand operations in Wisconsin because of our strong business climate and dedicated workforce," noted Wisconsin Lt. Gov. Rebecca Kleefisch in a news release. The Wisconsin Economic Development Corp. has authorized up to $350,000 in state income tax credits over the next four years, contingent on job creation and level of capital investment during that period.
Looking for chemical products? Let suppliers reach out to you!
2026-07-18
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and Application of Innovative Drugs
-
The Rare Disease Market Continues to Heat Up. How Will The Global Top 10 Pharmaceutical Companies by Revenue in 2021 be Deployed?
Recommend Reading
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Cost-driven fluctuations and decline in phthalic anhydride market prices in 2025; prices may first strengthen and then stabilize in 2026
-
IMCD Opens Beauty and Personal Care Lab in California
-
The Most Striking Thing in BASF’s 2025 Results Isn’t Profit — It’s “Cutting Weight” and “Stopping the Bleeding” at the Same Time
-
This week, ethylene glycol prices in China began to fall
-
BASF Moves to Sell 4,400 Employee Homes—Union Fury Reveals the Survival Math of a Chemical Giant